Vail David D - OmicsDI

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

Prospective molecular profiling of canine cancers provides a clinically relevant comparative model for evaluating precision medicine (PMed) trials

Feasibility trial to examine the ability to conduct molecular guided therapy in a geographically distributed systems within strict time constraints Canine patients were enrolled across a broad panel of tumor types where tumor samples were acquired and processed to preserve RNA quality for genomic an...

ORGANISM(S): Canis lupus

2014-04-28 | E-GEOD-51131 | biostudies-arrayexpress

Comparative Transcriptional Analysis of Canine and Human Diffuse Large B cell Lymphoma (DLBCL). Molecular Signatures of NF-?B Pathway Activation and Sub-Classification of Canine DLBCL.

In this study, we present the first comparison of global transcriptional changes taking place in canine lymphoma and human diffuse large B-cell lymphoma (DLBCL), with particular reference to the nuclear factor-kappaB (NF-?B) pathway. Microarray data generated from lymph nodes diagnosed with canine D...

ORGANISM(S): Canis lupus familiaris

2013-09-26 | E-GEOD-30881 | biostudies-arrayexpress

ALG1-CDG: Clinical and Molecular Characterization of 39 Unreported Patients.

Not available

S-EPMC4907823 | biostudies-literature

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Not available

S-EPMC10957483 | biostudies-literature

Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.

Not available

S-EPMC11872607 | biostudies-literature

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.